Formal incorporation has been completed under the name CHIL, derived from the English pronunciation of the founders’ surname. We now enter the next phase of operational execution and strategic growth.
Backed by more than a decade of experience in the diagnostics field, the founders are committed to developing well-structured projects that address critical industry gaps and emerging opportunities over the years ahead. Rather than simply integrating into the existing system, the company is set to develop new mechanisms that will contribute to reshaping it, supported by a clear strategic roadmap for long-term impact.